Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Research Findings Are Not a Personal Treatment Recommendation The way Retatrutide works in clinical research does not guarantee a specific amount of weight loss or a particular health outcome for an individual patient
The copper component creates oxidation vulnerabilities that limit stability compared to other peptides
The free assessment quiz determines clinical eligibility in about 5 minutes before any tirzepatide prescription is written
Ozempic (semaglutide) and Mounjaro (tirzepatide) can both lead to weight loss, but they are only FDAapproved to treat type 2 diabetes, not for weight management
Biomarker assessment through PlexusDx includes baseline metabolic and pancreatic enzyme evaluation, which establishes whether pre-existing pancreatic inflammation or dysfunction is present before GLP-1 therapy begins
